|
TG Therapeutics, Inc. is a specialty healthcare product company focused on developing and commercializing innovative treatments for underserved patient populations.
|
| Stock Information
|
OTCBB:TGTXD
$6.25
+ 0.05
|
May 17, 2012
10:42 AM ET |
Quotes delayed at least 20 minutes. Information provided by eSignal.

|